The process involves administering a sonosensitizer to the patient, which preferentially accumulates in cancer cells. Once the sonosensitizer is adequately localized, ultrasound waves are applied to the targeted area. The interaction between the ultrasound and the sonosensitizer generates ROS, causing oxidative stress and damage to the cancer cells, ultimately leading to their death.
